Cargando…
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a health problem that results in death, commonly due to the development of pulmonary hypertension (PH). Here, by utilizing a mouse model of intratracheal elastase-induced emphysema that presents three different phases of COPD, we sought to...
Autores principales: | Suraya, Ratoe, Nagano, Tatsuya, Ryanto, Gusty Rizky Teguh, Effendi, Wiwin Is, Hazama, Daisuke, Katsurada, Naoko, Yamamoto, Masatsugu, Tachihara, Motoko, Emoto, Noriaki, Nishimura, Yoshihiro, Kobayashi, Kazuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238100/ https://www.ncbi.nlm.nih.gov/pubmed/35761394 http://dx.doi.org/10.1186/s12931-022-02081-y |
Ejemplares similares
-
Mitochondrial Dysfunction in Pulmonary Hypertension
por: Ryanto, Gusty Rizky Teguh, et al.
Publicado: (2023) -
Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021) -
Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going
por: Haryono, Andreas, et al.
Publicado: (2022) -
Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension
por: Ryanto, Gusty Rizky Teguh, et al.
Publicado: (2023) -
Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)